Camstar Ingredients Limited - Limited company accounts 23.2

Camstar Ingredients Limited - Limited company accounts 23.2


IRIS Accounts Production v23.3.1.45 07849130 Board of Directors Board of Directors 1.4.22 31.3.23 31.3.23 true false true true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure078491302022-03-31078491302023-03-31078491302022-04-012023-03-31078491302021-03-31078491302021-04-012022-03-31078491302022-03-3107849130ns16:EnglandWales2022-04-012023-03-3107849130ns15:PoundSterling2022-04-012023-03-3107849130ns11:Director12022-04-012023-03-3107849130ns11:Director22022-04-012023-03-3107849130ns11:CompanySecretary12022-04-012023-03-3107849130ns11:PrivateLimitedCompanyLtd2022-04-012023-03-3107849130ns11:FRS1022022-04-012023-03-3107849130ns11:Audited2022-04-012023-03-3107849130ns11:LargeMedium-sizedCompaniesRegimeForDirectorsReport2022-04-012023-03-3107849130ns11:LargeMedium-sizedCompaniesRegimeForAccounts2022-04-012023-03-3107849130ns11:FullAccounts2022-04-012023-03-3107849130ns11:OrdinaryShareClass12022-04-012023-03-3107849130ns11:Director32022-04-012023-03-3107849130ns11:Director42022-04-012023-03-3107849130ns11:RegisteredOffice2022-04-012023-03-3107849130ns11:Director52022-04-012023-03-3107849130ns6:CurrentFinancialInstruments2023-03-3107849130ns6:CurrentFinancialInstruments2022-03-3107849130ns6:Non-currentFinancialInstruments2023-03-3107849130ns6:Non-currentFinancialInstruments2022-03-3107849130ns6:ShareCapital2023-03-3107849130ns6:ShareCapital2022-03-3107849130ns6:SharePremium2023-03-3107849130ns6:SharePremium2022-03-3107849130ns6:CapitalRedemptionReserve2023-03-3107849130ns6:CapitalRedemptionReserve2022-03-3107849130ns6:RetainedEarningsAccumulatedLosses2023-03-3107849130ns6:RetainedEarningsAccumulatedLosses2022-03-3107849130ns6:ShareCapital2021-03-3107849130ns6:RetainedEarningsAccumulatedLosses2021-03-3107849130ns6:SharePremium2021-03-3107849130ns6:CapitalRedemptionReserve2021-03-3107849130ns6:RetainedEarningsAccumulatedLosses2021-04-012022-03-3107849130ns6:CapitalRedemptionReserve2021-04-012022-03-3107849130ns6:RetainedEarningsAccumulatedLosses2022-04-012023-03-3107849130ns6:CapitalRedemptionReserve2022-04-012023-03-3107849130ns6:ShortLeaseholdAssetsns6:LandBuildings2022-04-012023-03-3107849130ns6:PlantMachinery2022-04-012023-03-3107849130ns6:FurnitureFittings2022-04-012023-03-3107849130ns6:ComputerEquipment2022-04-012023-03-3107849130ns11:HighestPaidDirector2022-04-012023-03-3107849130ns11:HighestPaidDirector2021-04-012022-03-3107849130ns6:PlantEquipmentOtherAssetsUnderOperatingLeases2022-04-012023-03-3107849130ns6:PlantEquipmentOtherAssetsUnderOperatingLeases2021-04-012022-03-3107849130ns6:OwnedAssets2022-04-012023-03-3107849130ns6:OwnedAssets2021-04-012022-03-3107849130ns6:LeasedAssets2022-04-012023-03-3107849130ns6:LeasedAssets2021-04-012022-03-310784913012022-04-012023-03-310784913012021-04-012022-03-3107849130ns6:HirePurchaseContracts2022-04-012023-03-3107849130ns6:HirePurchaseContracts2021-04-012022-03-3107849130ns6:ShortLeaseholdAssetsns6:LandBuildings2022-03-3107849130ns6:PlantMachinery2022-03-3107849130ns6:FurnitureFittings2022-03-3107849130ns6:ComputerEquipment2022-03-3107849130ns6:ShortLeaseholdAssetsns6:LandBuildings2023-03-3107849130ns6:PlantMachinery2023-03-3107849130ns6:FurnitureFittings2023-03-3107849130ns6:ComputerEquipment2023-03-3107849130ns6:ShortLeaseholdAssetsns6:LandBuildings2022-03-3107849130ns6:PlantMachinery2022-03-3107849130ns6:FurnitureFittings2022-03-3107849130ns6:ComputerEquipment2022-03-3107849130ns6:PlantMachineryns6:LeasedAssetsHeldAsLessee2022-03-3107849130ns6:PlantMachineryns6:LeasedAssetsHeldAsLessee2022-04-012023-03-3107849130ns6:PlantMachineryns6:LeasedAssetsHeldAsLessee2023-03-3107849130ns6:PlantMachineryns6:LeasedAssetsHeldAsLessee2022-03-3107849130ns6:WithinOneYearns6:CurrentFinancialInstruments2023-03-3107849130ns6:WithinOneYearns6:CurrentFinancialInstruments2022-03-3107849130ns6:WithinOneYearns6:CurrentFinancialInstrumentsns6:HirePurchaseContracts2023-03-3107849130ns6:WithinOneYearns6:CurrentFinancialInstrumentsns6:HirePurchaseContracts2022-03-3107849130ns6:BetweenOneFiveYearsns6:HirePurchaseContracts2023-03-3107849130ns6:BetweenOneFiveYearsns6:HirePurchaseContracts2022-03-3107849130ns6:HirePurchaseContracts2023-03-3107849130ns6:HirePurchaseContracts2022-03-3107849130ns6:WithinOneYear2023-03-3107849130ns6:WithinOneYear2022-03-3107849130ns6:BetweenOneFiveYears2023-03-3107849130ns6:BetweenOneFiveYears2022-03-3107849130ns6:AllPeriods2023-03-3107849130ns6:AllPeriods2022-03-3107849130ns6:Secured2023-03-3107849130ns6:Secured2022-03-3107849130ns6:DeferredTaxation2022-03-3107849130ns6:DeferredTaxation2022-04-012023-03-3107849130ns6:DeferredTaxation2023-03-3107849130ns11:OrdinaryShareClass12023-03-3107849130ns6:RetainedEarningsAccumulatedLosses2022-03-3107849130ns6:SharePremium2022-03-3107849130ns6:CapitalRedemptionReserve2022-03-31
REGISTERED NUMBER: 07849130 (England and Wales)











Strategic Report, Report of the Directors and

Financial Statements for the Year Ended 31 March 2023

for

Camstar Ingredients Limited

Camstar Ingredients Limited (Registered number: 07849130)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 5

Income Statement 9

Other Comprehensive Income 10

Balance Sheet 11

Statement of Changes in Equity 12

Cash Flow Statement 13

Notes to the Cash Flow Statement 14

Notes to the Financial Statements 15


Camstar Ingredients Limited

Company Information
for the Year Ended 31 March 2023







DIRECTORS: E J B Starke
Miss T Clark
B Land
M T Hoxworth





SECRETARY: Miss T Clark





REGISTERED OFFICE: Chestnuts Farm
Langton Green
Eye
Suffolk
IP23 7HL





REGISTERED NUMBER: 07849130 (England and Wales)





AUDITORS: Knights Lowe Limited
Chartered Accountants
and Statutory Auditors
Eldo House, Kempson Way
Suffolk Business Park
Bury St Edmunds
Suffolk
IP32 7AR

Camstar Ingredients Limited (Registered number: 07849130)

Strategic Report
for the Year Ended 31 March 2023

The directors present their strategic report for the year ended 31 March 2023.

REVIEW OF BUSINESS
This year has been a challenging year for Camstar Ingredients with a number of issues being faced.

A rapidly growing business has led to significantly increased turnover over the last few years, however due to increased interest rates and inflation along with fixed sales pricing and the first full year trading after the Pandemic, this has caused a challenging year.

Performance has improved for the current financial period going forward and the company has traded through these issues, identified the problems and worked to fix these.

We continue to increase the business across the many areas such as Heat Treatment, Wet Sauces, Blending and Roasting to create added value and are optimistic for the future.

Key performance indicators
The key performance indicators for Camstar Ingredients Ltd are net profit margin and gross profit margin. The company have chosen these to represent the company's performance and position as increasing turnover has been a key objective for the company in recent years. Net profit is a key indicator for the company as it gives a more holistic view of how the company is performing and allows them to review their costs for maximum efficiencies.

The results for the year, as shown on the statement of comprehensive income, shows a gross profit margin of 12.7% (2022: 23.4%) and net profit margin of -4.8% (2022: 7.9%).

Revenue has increased from £12.3m to £13.8m in 2023.

ON BEHALF OF THE BOARD:





Miss T Clark - Secretary


20 December 2023

Camstar Ingredients Limited (Registered number: 07849130)

Report of the Directors
for the Year Ended 31 March 2023

The directors present their report with the financial statements of the company for the year ended 31 March 2023.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of production and sale of spice blends and sauces.

DIVIDENDS
No dividends will be distributed for the year ended 31 March 2023.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 April 2022 to the date of this report.

E J B Starke
Miss T Clark
B Land
M T Hoxworth

Other changes in directors holding office are as follows:

Mrs A Mizgier - appointed 6 July 2022 - resigned 11 November 2022

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

Camstar Ingredients Limited (Registered number: 07849130)

Report of the Directors
for the Year Ended 31 March 2023


AUDITORS
The auditors, Knights Lowe Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:



Miss T Clark - Secretary


20 December 2023

Report of the Independent Auditors to the Members of
Camstar Ingredients Limited

Opinion
We have audited the financial statements of Camstar Ingredients Limited (the 'company') for the year ended 31 March 2023 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 March 2023 and of its loss for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Report of the Independent Auditors to the Members of
Camstar Ingredients Limited


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Report of the Independent Auditors to the Members of
Camstar Ingredients Limited


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

- the engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;
- we identified the laws and regulations applicable to the company through discussions with directors and other management, and from our commercial knowledge and experience of the companies operating sector;
- we focused on specific laws and regulations which we considered may have a direct material effect on the financial statements or the operations of the company, including the Companies Act 2006, taxation legislation, data protection, anti-bribery, employment, environmental and health and safety legislation ;
- we assessed the extent of compliance with the laws and regulations identified above through making enquiries of management and inspecting legal correspondence; and
- identified laws and regulations were communicated within the audit team regularly and the team remained alert to instances of non-compliance throughout the audit.

We assessed the susceptibility of the company's financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:
- making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud;
- considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations; and

To address the risk of fraud through management bias and override of controls, we:
- performed analytical procedures to identify any unusual or unexpected relationships;
- tested journal entries to identify unusual transactions;
- assessed whether judgements and assumptions made in determining the accounting estimates were indicative of potential bias;
- investigated the rationale behind significant or unusual transactions; and

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:
- agreeing financial statement disclosures to underlying supporting documentation;
- reading the minutes of meetings of those charged with governance;
- enquiring of management as to actual and potential litigation and claims;
- reviewing correspondence with HMRC and the company's legal advisors;

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Report of the Independent Auditors to the Members of
Camstar Ingredients Limited


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




James Knights BSc FCA (Senior Statutory Auditor)
for and on behalf of Knights Lowe Limited
Chartered Accountants
and Statutory Auditors
Eldo House, Kempson Way
Suffolk Business Park
Bury St Edmunds
Suffolk
IP32 7AR

21 December 2023

Camstar Ingredients Limited (Registered number: 07849130)

Income Statement
for the Year Ended 31 March 2023

2023 2022
Notes £    £    £    £   

TURNOVER 13,786,805 12,262,199

Cost of sales 12,032,287 9,388,648
GROSS PROFIT 1,754,518 2,873,551

Distribution costs 408,698 339,384
Administrative expenses 1,907,210 1,507,976
2,315,908 1,847,360
OPERATING (LOSS)/PROFIT 4 (561,390 ) 1,026,191

Interest receivable and similar income 466 -
(560,924 ) 1,026,191

Interest payable and similar expenses 5 101,428 56,338
(LOSS)/PROFIT BEFORE TAXATION (662,352 ) 969,853

Tax on (loss)/profit 6 141,949 214,256
(LOSS)/PROFIT FOR THE FINANCIAL YEAR (804,301 ) 755,597

Camstar Ingredients Limited (Registered number: 07849130)

Other Comprehensive Income
for the Year Ended 31 March 2023

2023 2022
Notes £    £   

(LOSS)/PROFIT FOR THE YEAR (804,301 ) 755,597


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME FOR THE
YEAR

(804,301

)

755,597

Camstar Ingredients Limited (Registered number: 07849130)

Balance Sheet
31 March 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 7 2,256,231 1,764,631

CURRENT ASSETS
Stocks 8 2,156,868 2,367,332
Debtors 9 1,926,434 2,209,720
Cash at bank 4,347 113,127
4,087,649 4,690,179
CREDITORS
Amounts falling due within one year 10 4,055,085 3,718,595
NET CURRENT ASSETS 32,564 971,584
TOTAL ASSETS LESS CURRENT LIABILITIES 2,288,795 2,736,215

CREDITORS
Amounts falling due after more than one
year

11

(404,006

)

(189,074

)

PROVISIONS FOR LIABILITIES 15 (451,606 ) (309,657 )
NET ASSETS 1,433,183 2,237,484

CAPITAL AND RESERVES
Called up share capital 16 990 990
Share premium 17 4,165 4,165
Capital redemption reserve 17 80 80
Retained earnings 17 1,427,948 2,232,249
SHAREHOLDERS' FUNDS 1,433,183 2,237,484

The financial statements were approved by the Board of Directors and authorised for issue on 20 December 2023 and were signed on its behalf by:




E J B Starke - Director



Miss T Clark - Director


Camstar Ingredients Limited (Registered number: 07849130)

Statement of Changes in Equity
for the Year Ended 31 March 2023

Called up Capital
share Retained Share redemption Total
capital earnings premium reserve equity
£    £    £    £    £   
Balance at 1 April 2021 990 1,476,652 4,165 80 1,481,887

Changes in equity
Total comprehensive income - 755,597 - - 755,597
Balance at 31 March 2022 990 2,232,249 4,165 80 2,237,484

Changes in equity
Total comprehensive income - (804,301 ) - - (804,301 )
Balance at 31 March 2023 990 1,427,948 4,165 80 1,433,183

Camstar Ingredients Limited (Registered number: 07849130)

Cash Flow Statement
for the Year Ended 31 March 2023

2023 2022
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 391,599 1,049,904
Interest paid (84,668 ) (40,866 )
Interest element of hire purchase payments
paid

(16,760

)

(15,472

)
Tax paid (50,895 ) (64,882 )
Net cash from operating activities 239,276 928,684

Cash flows from investing activities
Purchase of tangible fixed assets (724,929 ) (782,029 )
Sale of tangible fixed assets 25,000 -
Interest received 466 -
Net cash from investing activities (699,463 ) (782,029 )

Cash flows from financing activities
Intercompany loan 54,666 -
New HP 476,590 232,871
Capital repayments in year (179,849 ) (188,480 )
Net cash from financing activities 351,407 44,391

(Decrease)/increase in cash and cash equivalents (108,780 ) 191,046
Cash and cash equivalents at beginning of
year

2

113,127

(77,919

)

Cash and cash equivalents at end of year 2 4,347 113,127

Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Cash Flow Statement
for the Year Ended 31 March 2023

1. RECONCILIATION OF (LOSS)/PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS
2023 2022
£    £   
(Loss)/profit before taxation (662,352 ) 969,853
Depreciation charges 208,330 158,226
Loss on disposal of fixed assets - 1,005
Finance costs 101,428 56,338
Finance income (466 ) -
(353,060 ) 1,185,422
Decrease/(increase) in stocks 210,464 (853,315 )
Decrease/(increase) in trade and other debtors 283,286 (497,801 )
Increase in trade and other creditors 250,909 1,215,598
Cash generated from operations 391,599 1,049,904

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 March 2023
31.3.23 1.4.22
£    £   
Cash and cash equivalents 4,347 113,127
Year ended 31 March 2022
31.3.22 1.4.21
£    £   
Cash and cash equivalents 113,127 78
Bank overdrafts - (77,997 )
113,127 (77,919 )


3. ANALYSIS OF CHANGES IN NET DEBT

At 1.4.22 Cash flow At 31.3.23
£    £    £   
Net cash
Cash at bank 113,127 (108,780 ) 4,347
113,127 (108,780 ) 4,347
Debt
Finance leases (352,653 ) (296,741 ) (649,394 )
Debts falling due within 1 year (1,140,667 ) (91,231 ) (1,231,898 )
(1,493,320 ) (387,972 ) (1,881,292 )
Total (1,380,193 ) (496,752 ) (1,876,945 )

Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

Camstar Ingredients Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going concern
The effects of the global economic situation have been carefully considered when preparing these financial statements. These financial statements continue to be prepared on a going concern basis as the directors are confident that the company is in a strong financial position to continue to trade going forward.The company has the ongoing financial support of its immediate parent company Camstar Herbs Limited if required.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Leasehold improvements - 10 years straight line
Plant and machinery - 10% on reducing balance
Fixtures and fittings - 25% on reducing balance
Computer equipment - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

2. ACCOUNTING POLICIES - continued

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, and loans from banks or other related parties.

Debt instruments, like loans and other accounts receivable and payable, are initially measured at present value of the future payments and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade payables or receivables, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration, expected to be paid or received. However if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in case of an outright short-term loan not at market rate, the financial asset or liability is measured, initially and subsequently, at the present value of the future payment discounted at a market rate of interest for a similar debt instrument.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of Comprehensive Income.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate, which is an approximation of the amount that the company would receive for the asset if it were to be sold at the balance sheet date.

Financial assets and liabilities are offset and the net amount reported in the Balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

2. ACCOUNTING POLICIES - continued

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Impairment
At each reporting date tangible fixed assets are assessed to determine whether there is an indication that the carrying amount of an asset may be more than its recoverable amount and that the asset should be impaired. If there is an indication of possible impairment, the recoverable amount of an asset, which is the higher of its value in use and its net realisable value, is estimated and compared with its carrying amount. If the recoverable amount is lower, the carrying amount of the asset is written down to its estimated recoverable amount and an impairment loss is recognised in profit and loss.

3. EMPLOYEES AND DIRECTORS
2023 2022
£    £   
Wages and salaries 3,134,738 2,489,833
Social security costs 18,984 15,340
Other pension costs 29,990 20,622
3,183,712 2,525,795

The average number of employees during the year was as follows:
2023 2022

Directors 4 4
Other staff 59 48
63 52

2023 2022
£    £   
Directors' remuneration 251,659 241,648

Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

3. EMPLOYEES AND DIRECTORS - continued

Information regarding the highest paid director is as follows:
2023 2022
£    £   
Emoluments etc 120,000 120,000

4. OPERATING (LOSS)/PROFIT

The operating loss (2022 - operating profit) is stated after charging:

2023 2022
£    £   
Repairs & renewals 324,867 317,511
Other operating leases 157,226 133,245
Depreciation - owned assets 145,129 97,748
Depreciation - assets on hire purchase contracts 63,200 60,478
Loss on disposal of fixed assets - 1,005
Auditors' remuneration 4,000 2,000
Foreign exchange differences 1,894 1,214

5. INTEREST PAYABLE AND SIMILAR EXPENSES
2023 2022
£    £   
Bank & group finance interest 81,513 37,495
Bank charges 3,155 3,371
Hire purchase interest 16,760 15,472
101,428 56,338

6. TAXATION

Analysis of the tax charge
The tax charge on the loss for the year was as follows:
2023 2022
£    £   
Current tax:
UK corporation tax - 50,895
Adjustment re: previous years - (22,870 )
Total current tax - 28,025

Deferred tax 141,949 186,231
Tax on (loss)/profit 141,949 214,256

UK corporation tax was charged at 19%) in 2022.

Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

6. TAXATION - continued

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2023 2022
£    £   
(Loss)/profit before tax (662,352 ) 969,853
(Loss)/profit multiplied by the standard rate of corporation tax in the UK
of 19% (2022 - 19%)

(125,847

)

184,272

Effects of:
Expenses not deductible for tax purposes 2,561 1,176
Capital allowances in excess of depreciation (146,841 ) (135,019 )
Group relieved losses 270,127 -
Enhanced R&D tax relief - (22,404 )
Deferred tax adjustment 141,949 186,231
Total tax charge 141,949 214,256

7. TANGIBLE FIXED ASSETS
Fixtures
Leasehold Plant and and Computer
improvements machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 April 2022 355,805 1,930,036 25,133 30,259 2,341,233
Additions 37,149 679,559 - 8,221 724,929
Disposals - (25,000 ) - - (25,000 )
At 31 March 2023 392,954 2,584,595 25,133 38,480 3,041,162
DEPRECIATION
At 1 April 2022 59,022 484,072 14,539 18,969 576,602
Charge for year 37,520 163,930 2,649 4,230 208,329
At 31 March 2023 96,542 648,002 17,188 23,199 784,931
NET BOOK VALUE
At 31 March 2023 296,412 1,936,593 7,945 15,281 2,256,231
At 31 March 2022 296,783 1,445,964 10,594 11,290 1,764,631

Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

7. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Plant and
machinery
£   
COST
At 1 April 2022 596,219
Additions 476,590
At 31 March 2023 1,072,809
DEPRECIATION
At 1 April 2022 80,765
Charge for year 63,200
At 31 March 2023 143,965
NET BOOK VALUE
At 31 March 2023 928,844
At 31 March 2022 515,454

8. STOCKS
2023 2022
£    £   
Stocks 2,156,868 2,367,332

9. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 1,598,581 1,929,916
Other debtors 95,048 81,818
Directors' loan accounts 8 8
Prepayments 232,797 197,978
1,926,434 2,209,720

10. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Other loans (see note 12) 1,231,898 1,140,667
Hire purchase contracts (see note 13) 245,388 163,579
Trade creditors 1,814,935 1,722,465
Amounts owed to group undertakings 562,648 507,982
Corporation tax - 50,895
Social security and other taxes 129,798 48,824
Accruals 70,418 84,183
4,055,085 3,718,595

Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

11. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2023 2022
£    £   
Hire purchase contracts (see note 13) 404,006 189,074

12. LOANS

An analysis of the maturity of loans is given below:

2023 2022
£    £   
Amounts falling due within one year or on demand:
Other loans 1,231,898 1,140,667

13. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase contracts
2023 2022
£    £   
Net obligations repayable:
Within one year 245,388 163,579
Between one and five years 404,006 189,074
649,394 352,653

Non-cancellable operating leases
2023 2022
£    £   
Within one year 16,157 688
Between one and five years 32,190 113
48,347 801

Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

14. SECURED DEBTS

The following secured debts are included within creditors:

2023 2022
£    £   
Other loans 1,231,898 1,140,667
Hire purchase contracts 649,394 352,653
1,881,292 1,493,320

Hire purchase liabilities are secured over the assets financed.

The bank hold a fixed and floating charge over all assets of the company to act as security for the invoice finance facility held by the company and also as security in relation to borrowing within the parent company, Camstar Herbs Limited.

15. PROVISIONS FOR LIABILITIES
2023 2022
£    £   
Deferred tax
Accelerated capital allowances 451,606 309,657

Deferred
tax
£   
Balance at 1 April 2022 309,657
Provided during year 141,949
Balance at 31 March 2023 451,606

16. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
990 Ordinary £1 990 990

17. RESERVES
Capital
Retained Share redemption
earnings premium reserve Totals
£    £    £    £   

At 1 April 2022 2,232,249 4,165 80 2,236,494
Deficit for the year (804,301 ) (804,301 )
At 31 March 2023 1,427,948 4,165 80 1,432,193

Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

18. ULTIMATE PARENT COMPANY

Camstar Herbs Limited is regarded by the directors as being the company's ultimate parent company.

19. CONTINGENT LIABILITIES

Camstar Ingredients Limited guarantees the bank finance of its parent company Camstar Herbs Limited. The outstanding value of this loan in Camstar Herbs Limited at 31 March 2023 is £14,726,041 (2022: £15,017,612)

20. CAPITAL COMMITMENTS
2023 2022
£    £   
Contracted but not provided for in the
financial statements 29,394 62,054

21. ULTIMATE PARENT COMPANY

The ultimate parent company is Starke Industries Limited.
Registered Office : Chestnuts Farm, Langton Green, Eye, Suffolk, IP23 7HL